BVF PARTNERS L P/IL Insider Trading $RGEN REPLIGEN CORP
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in KENT INTERNATIONAL HOLDINGS INC ($CRTQ) and 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and 10% Owner in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in REPLIGEN CORP ($RGEN) and 10% Owner in AVIGEN INC \DE ($AVGN) and 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and 10% Owner in Astex Pharmaceuticals, Inc ($SUPG) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ ($NTII) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ICAGEN INC ($ICGN) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in Celera CORP ($CRA) and 10% Owner in ABBOTT BIOTHERAPEUTICS CORP ($FACT).
BVF PARTNERS L P/IL in REPLIGEN CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 2,765,050 shares
Current Value: $80,850,062
Latest Transaction: Jul 08 2009
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in REPLIGEN CORP
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, FACT, ARQL, ARRY, SUPG, AVGN, CAPS, CBIO, CRA, CCXI, DVAX, CRXX, ICGN, CRTQ, LGND, NTII, NBIX, RGEN, RIGL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 08 2009 | RGEN | REPLIGEN CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 5.50 | 1,000 | 5,500 | 2,765,050 | 2.8 M to 2.8 M (-0.04 %) |
| Jul 08 2009 | RGEN | REPLIGEN CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 5.52 | 264,000 | 1,456,145 | 2,766,050 | 3 M to 2.8 M (-8.71 %) |
| Jul 08 2009 | RGEN | REPLIGEN CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 5.52 | 76,000 | 419,193 | 3,030,050 | 3.1 M to 3 M (-2.45 %) |
| Jul 08 2009 | RGEN | REPLIGEN CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 5.52 | 110,800 | 611,140 | 3,106,050 | 3.2 M to 3.1 M (-3.44 %) |
Page: 1